全部文献期刊学位论文会议报纸专利标准年鉴图书|学者科研项目
中外文文献  中文文献  外文文献
作者:Pamela Tiet , Matthew D. Gallovic ...
来源:[J].Biomaterials(IF 7.604), 2019, Vol.205, pp.94-105Elsevier
摘要:Abstract(#br)Immunotherapies have significantly improved cancer patient survival, but response rates are still limited. Thus, novel formulations are needed to expand the breadth of immunotherapies. Pathogen associated molecular patterns (PAMPs) can be used to stimulate an immune ...
作者:Pamela Tiet , Jenny P.-Y. Ting ...
来源:[J].Journal of Controlled Release(IF 7.633), 2018, Vol.289, pp.114-124Elsevier
摘要:Abstract(#br)Influenza places a significant health and economic burden on society. Efficacy of seasonal influenza vaccines can be suboptimal due to poor matching between vaccine and circulating viral strains. An influenza vaccine that is broadly protective against multiple v...
作者:Pamela Tiet , Naihan Chen ...
来源:[J].International Journal of Pharmaceutics(IF 3.458), 2018, Vol.552 (1-2), pp.371-377Elsevier
摘要:Abstract(#br)While highly active antiretroviral therapy (HAART) has significantly reduced mortality rates in patients with human immunodeficiency virus type 1 (HIV-1), its efficacy may be impeded by emergence of drug resistance caused by lack of patient adherence. A therapeu...
作者:Pamela Tiet , Jacob M Berlin
来源:[J].Biochemical Pharmacology(IF 4.576), 2017, Vol.145, pp.18-26Elsevier
摘要:Abstract(#br)Off target toxicities is one of the hallmarks of conventional chemotherapy as only a tiny percentage of the injected dose actually reaches the tumor(s). Numerous strategies have been employed in attempts to achieve targeted therapeutic delivery to tumors. One st...
作者:Pamela Tiet , Eric M. Bachelder
来源:[J].Pharmaceutical Nanotechnology, 2018, Vol.6 (4), pp.232-244Bentham
摘要:Cancer cells are able to avoid immune surveillance and exploit the immune system togrow and metastasize. With the development of nano- and micro-particles, there has been a growingnumber of immunotherapy delivery systems developed to elicit innate and adaptive immune responsesto ...

我们正在为您处理中,这可能需要一些时间,请稍等。

资源合作:cnki.scholar@cnki.net, +86-10-82896619   意见反馈:scholar@cnki.net

×